NeuroBo Pharmaceuticals | 8-K: Neurobo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of Da-1241 in Combination with Sitagliptin and Opens Enrollment for Part 2 of Its Phase 2a Clinical Trial Evaluating Da-1241 for the Treatment of Mash
NeuroBo Pharmaceuticals | 8-K: Neurobo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of Da-1241 in Combination with Sitagliptin and Opens Enrollment for Part 2 of Its Phase 2a Clinical Trial Evaluating Da-1241 for the Treatment of Mash
NeuroBo Pharmaceuticals | 8-K：NeuroBo Pharmaceuticals報告了DA-1241與西格列汀聯合使用的臨床前安全性數據陽性，並開放了其評估DA-1241治療麻疹的 2a 期臨床試驗第2部分的註冊